510(k) device
UltraCor Twirl Breast Tissue Marker
Bard Peripheral Vascular, Inc. · Marker, Radiographic, Implantable (NEU, Class II) · First FDA decision May 13, 2016, newest Mar 24, 2025Breast cancer
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
0
Naming "UltraCor Twirl Breast"
MAUDE reports
1
Brand "UltraCor Twirl Breast", since 2015
PubMed studies
0
Mentioning "UltraCor Twirl Breast"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing UltraCor Twirl Breast Tissue Marker
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K243642 · Decided Mar 24, 2025 · 118 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
K180061 · Decided Mar 9, 2018 · 60 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
K152510 · Decided May 13, 2016 · 254 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "UltraCor Twirl Breast", any status and sponsor, newest update first.
No registered device study names "UltraCor Twirl Breast".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "UltraCor Twirl Breast", and for the whole product code for context.
This brand
1 reports: 1 malfunction, 0 injury, 0 death
Whole product code NEU
1,678 reports: 518 malfunction, 1,149 injury, 1 death
Newest reports for this brand
- ULTRACOR TWIRL BREAST TISSUE MARKERMalfunction
BARD PERIPHERAL VASCULAR, INC.
2020394-2018-00757 · Received May 30, 2018 · Event dated May 3, 2018
Device type: Marker, Radiographic, Implantable (NEU)
Device problem as coded: Tear, Rip or Hole in Device Packaging
Patient problem as coded: No Patient Involvement
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "UltraCor Twirl Breast"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NEU.
- HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc. · 510(k) 2022
- MOLLI 2 SystemMolli Surgical, Inc. · 510(k) 2024
- HydroMARK Plus Breast Biopsy Site Marker (Dragonfly Shape)Devicor Medical Products, Inc. · 510(k) 2026
- RFID Localization SystemHealth Beacons, Inc. · 510(k) 2020
- Cianna Medical SAVI Scout Reflector and SAVI Scout SystemCianna Medical, Inc. · 510(k) 2018
- Beacon Tissue Marker (SE)Scion Medical Technologies, LLC · 510(k) 2015
- Biopsy Sciences, Inc. Hydromark Brest Biosy Site MarkerBiopsy Sciences, LLC · 510(k) 2012
- Securmark Biopsy Site Marking SystemSuros Surgical Systems, Inc. A Hologic Company · 510(k) 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.